These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 30905792)

  • 21. Review of dermatologic medications and impact on male fertility, sexual dysfunction and teratogenicity.
    Hui EX; Huang X; Oon HH
    Andrology; 2022 Oct; 10(7):1272-1285. PubMed ID: 35876714
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dermatological medication effects on male fertility.
    Millsop JW; Heller MM; Eliason MJ; Murase JE
    Dermatol Ther; 2013; 26(4):337-46. PubMed ID: 23914891
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidence and Prevalence of Sexual Dysfunction in Women and Men: A Consensus Statement from the Fourth International Consultation on Sexual Medicine 2015.
    McCabe MP; Sharlip ID; Lewis R; Atalla E; Balon R; Fisher AD; Laumann E; Lee SW; Segraves RT
    J Sex Med; 2016 Feb; 13(2):144-52. PubMed ID: 26953829
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Medications and sexual function.
    Thomas DR
    Clin Geriatr Med; 2003 Aug; 19(3):553-62. PubMed ID: 14567007
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Impact of Thyroid Disease on Sexual Dysfunction in Men and Women.
    Gabrielson AT; Sartor RA; Hellstrom WJG
    Sex Med Rev; 2019 Jan; 7(1):57-70. PubMed ID: 30057137
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thalidomide and sexual dysfunction in men.
    Pouaha J; Martin S; Reichert-Pénétrat S; Tréchot P; Barbaud A; Schmutz JL;
    Br J Dermatol; 2002 Jun; 146(6):1112-3. PubMed ID: 12072099
    [No Abstract]   [Full Text] [Related]  

  • 27. Persistent Sexual and Nonsexual Adverse Effects of Finasteride in Younger Men.
    Irwig MS
    Sex Med Rev; 2014 Jan; 2(1):24-35. PubMed ID: 27784541
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adverse side effects of 5α-reductase inhibitors therapy: persistent diminished libido and erectile dysfunction and depression in a subset of patients.
    Traish AM; Hassani J; Guay AT; Zitzmann M; Hansen ML
    J Sex Med; 2011 Mar; 8(3):872-84. PubMed ID: 21176115
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characteristics of Men Who Report Persistent Sexual Symptoms After Finasteride Use for Hair Loss.
    Basaria S; Jasuja R; Huang G; Wharton W; Pan H; Pencina K; Li Z; Travison TG; Bhawan J; Gonthier R; Labrie F; Dury AY; Serra C; Papazian A; O'Leary M; Amr S; Storer TW; Stern E; Bhasin S
    J Clin Endocrinol Metab; 2016 Dec; 101(12):4669-4680. PubMed ID: 27662439
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sexual Dysfunction Related to Drugs: a Critical Review. Part V: α-Blocker and 5-ARI Drugs.
    La Torre A; Giupponi G; Duffy D; Conca A; Cai T; Scardigli A
    Pharmacopsychiatry; 2016 Jan; 49(1):3-13. PubMed ID: 26569417
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sexual function in men with lower urinary tract symptoms and prostatic enlargement secondary to benign prostatic hyperplasia: results of a 6-month, randomized, double-blind, placebo-controlled study of tadalafil coadministered with finasteride.
    Glina S; Roehrborn CG; Esen A; Plekhanov A; Sorsaburu S; Henneges C; Büttner H; Viktrup L
    J Sex Med; 2015 Jan; 12(1):129-38. PubMed ID: 25353053
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of medical treatments for male lower urinary tract symptoms due to benign prostatic hyperplasia on ejaculatory function: a systematic review and meta-analysis.
    Gacci M; Ficarra V; Sebastianelli A; Corona G; Serni S; Shariat SF; Maggi M; Zattoni F; Carini M; Novara G
    J Sex Med; 2014 Jun; 11(6):1554-66. PubMed ID: 24708055
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Time Course of Incident Adverse Experiences Associated with Doxazosin, Finasteride and Combination Therapy in Men with Benign Prostatic Hyperplasia: The MTOPS Trial.
    Kaplan SA; Lee JY; Meehan AG; Kusek JW
    J Urol; 2016 Jun; 195(6):1825-9. PubMed ID: 26678956
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk factors associated with primary and secondary reduced libido in male patients with sexual dysfunction.
    Corona G; Rastrelli G; Ricca V; Jannini EA; Vignozzi L; Monami M; Sforza A; Forti G; Mannucci E; Maggi M
    J Sex Med; 2013 Apr; 10(4):1074-89. PubMed ID: 23347078
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Strategies for managing sexual dysfunction induced by antidepressant medication.
    Taylor MJ; Rudkin L; Bullemor-Day P; Lubin J; Chukwujekwu C; Hawton K
    Cochrane Database Syst Rev; 2013 May; (5):CD003382. PubMed ID: 23728643
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of Psychotropic Drug-Induced DRESS Syndrome: A Systematic Review.
    Bommersbach TJ; Lapid MI; Leung JG; Cunningham JL; Rummans TA; Kung S
    Mayo Clin Proc; 2016 Jun; 91(6):787-801. PubMed ID: 27126302
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multicenter study on the prevalence of sexual symptoms in male hypo- and hyperthyroid patients.
    Carani C; Isidori AM; Granata A; Carosa E; Maggi M; Lenzi A; Jannini EA
    J Clin Endocrinol Metab; 2005 Dec; 90(12):6472-9. PubMed ID: 16204360
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of sexual function in subjects taking finasteride for the treatment of androgenetic alopecia.
    Tosti A; Piraccini BM; Soli M
    J Eur Acad Dermatol Venereol; 2001 Sep; 15(5):418-21. PubMed ID: 11763381
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Topiramate-associated sexual dysfunction: A systematic review.
    Chen LW; Chen MY; Chen KY; Lin HS; Chien CC; Yin HL
    Epilepsy Behav; 2017 Aug; 73():10-17. PubMed ID: 28605628
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sexual dysfunction in schizophrenia: focus on recent evidence.
    Baggaley M
    Hum Psychopharmacol; 2008 Apr; 23(3):201-9. PubMed ID: 18338766
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.